Navigation Links
A New Addition Could Help Patients With Parkinson’s Disease

Researchers say by adding the drug rasagiline to standard treatment with levodopa can reduce the amount of time Parkinson’s disease // patients spend suffering from motor fluctuations they experience during the day .

For the study researchers compared once-daily oral rasagiline to the drug entacapone, which must be taken with every levodopa dose, and a placebo in around 690 patients. Both of the additional drugs were effective in reducing the amount of “off time” defined as periods during the day when patients have symptoms. Rasagiline reduced “off time” on average by 1.18 hours, compared to 1.2 hours for entacapone. The drug was also found to be well-tolerated in the older age groups, with no evidence of an increase in hallucinations or occurrence of other common side effects of Parkinson’s drugs, such as daytime sleepiness, nausea, and leg swelling.

In conclusion researchers say they feel that the drug is likely to find favor with both neurologists and geriatricians as a useful addition to Parkinson’s disease therapeuics.
'"/>




Page: 1

Related medicine news :

1. Additional Radiotheraphy for Breast Cancer
2. Adding An Additional Drug May Help Patients With Glaucoma
3. The Addition Of Radiation Therapy Found To Improve Survival In Breast Cancer Patients
4. Addition Of Folic Acid In Flour Proposed To Arrest Birth Defects In The UK
5. Additional Responsiblities To Be Taken Up By Allied Healthcare Professionals
6. Britain Toddlers To Receive Flu-Jab In Addition To The 21 Shots
7. No More Additional Cases of Mad Cow Disease in Canada
8. Killing Power Of Bleach Enhanced By Addition Of Vinegar
9. Tackling Drug Addition in UK
10. Kellogg’s Additions to Wholesome Snack
11. NACO to Introduce 400 Additional AIDS/HIV Screening Centers
Post Your Comments:
(Date:9/5/2008)... Sept. 5 /PRNewswire/ -- EthicAd, a nonprofit orga...h consumer education, announces,the launch of a ne...better,understand direct-to-consumer (DTC) adverti...art About Prescription Drug Advertising," is,hoste...arch and was,developed by the FDA in partnership w...
(Date:9/5/2008)...risk is greatest for those overweight or obese at ...ws) -- Almost half of all American adults will dev...ir odds increase if they are obese in middle age, ...the painful condition increased as his or her body...y of North Carolina at Chapel Hill study. People w...
(Date:9/5/2008)...s say patients taking meds on Web site shouldn,t o... Sept. 5 (HealthDay News) -- The U.S. Food and Dru...te drugs being evaluated for potential safety issu...rs on a quarterly report, it means we have begun a...blem that requires further evaluation," Dr. Gerald...
(Date:9/5/2008)...Lung cancer risk prediction models are enhanced by...easuring DNA repair capacity, according to researc...f Texas M. D. Anderson Cancer Center in two comple... Cancer Prevention Research . , In the first st...nd unique results based on increased exposure to c...
Breaking Medicine News(10 mins):Health News:Prescription Drug Advertising Subject of New FDA Web Site for Consumers 2Health News:Almost Half of Adults Will Develop Knee Osteoarthritis by 85 2Health News:FDA to List Drugs Under Review for Safety Issues 2Health News:Creating lung cancer risk models for specific populations refines prediction 2Health News:Creating lung cancer risk models for specific populations refines prediction 3
...o treat kleptomania has failed to find any conclus...ng disorder,// according to researchers at the Sta...ts leave open the possibility that some medication...still be an effective treatment for certain patien...
...e lymphoblastic leukemia have a significantly incr...he general population. // Acute lymphoblastic leuk...lescents, with almost 4,000 new cases diagnosed in... one of the most curable pediatric cancers: surviv...
...h estradiol, the primary estrogen in humans mainta...it aids in avoiding osteoporosis. // It is well kn...nd that when the production of estrogen is reduced... women and pathogenically after exposure to radiat...
...asingly popular with college students, could be as...e the smoke is filtered through water in a hookah,...ved, the UPI news wire reported. "Links have been...hookah) usage and oral, lung and bladder cancer, i...
Other Medicine News:Health News:Study Finds No Conclusive Benefit from Treating Kleptomania 2Health News:Lymphoblastic Leukemia Survivors at Risk for Secondary Cancer 2Health News:Estradiol Guards Against Osteoporosis 2
(Date:9/4/2008)...d Presented at ESC Congress-, PHILADELPHIA, Sept....l,study, the GISSI Heart Failure (GISSI-HF) study,...rs reduced all cause mortality and hospital,admiss...hronic heart,failure. These findings are published... were presented at the European Cardiovascular Soc...
(Date:9/4/2008)...limumab to be Presented, PRINCETON, N.J., Sept. 4... MEDX ) announced today that nine clinical abstrac...antibody, in melanoma are scheduled to be,the subj...uropean Society,for Medical Oncology (ESMO) being ...he following abstracts will include updated one-ye...
(Date:9/3/2008)...Children Studied. Wrong,Conclusions Reached., NIX...rs for Disease,Control and Prevention (CDC) study ... MMR vaccine and autism. The National Autism Assoc...l the growing public concern over a,vaccine-autism...g design,and methodology., For years, parents hav...
(Date:9/3/2008)... /- Artelis SA and,Selexis SA announc...ntibody,production with the achievement of manufac...ord level was accomplished by applying two highly,...able Selexis CHO,production cell line rapidly gene... using their proprietary Selexis Genetic Elements(...
Breaking Medicine Technology:New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 2New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 3New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 4Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 2Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 3CDC Misses Target With Flawed MMR/Autism Study 2Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter 2Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter 3The Highmark Foundation Announces 241 Million School Challenge Program 6501 1The Highmark Foundation Announces 241 Million School Challenge Program 6501 2 245 M Gift Boosts Childhood Oral Health Care Offered by UW Childrens Hospital 6499 1 245 M Gift Boosts Childhood Oral Health Care Offered by UW Childrens Hospital 6499 2Neuromuscular Dentistry Ends Womans Migraines 6497 1Neuromuscular Dentistry Ends Womans Migraines 6497 2Bee strategy helps servers run more sweetly 1252 1Bee strategy helps servers run more sweetly 1252 2Bee strategy helps servers run more sweetly 1252 3
...onstrate Meaningful Placebo Adjusted Weight,Loss; ... 09, 2007 /PRNewswire-FirstCall/ -- Manhattan,Phar...ompany,s two,Phase 2a clinical trials of oral Oleo...ouble-blind, placebo-controlled studies, one,in co...nstrated no,statistically or clinically meaningful...
...PH20 with Humira Estimated to Increase the,Maximal...% to 100%,-, SAN DIEGO, July 09, 2007 /PRNewswire-...harmaceutical company developing and,commercializi...,final results of the Enhanze(TM) Technology clini...oavailability of a,representative commercially-ava...
Other Medicine Technology:Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for,Oral Oleoyl-estrone 2Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for,Oral Oleoyl-estrone 3Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for,Oral Oleoyl-estrone 4Halozyme Therapeutics' Enhanze Technology Large Protein Molecule,Therapeutic Clinical Trial Results Presented at the 34th Annual,Meeting of the Controlled Release Society 2Halozyme Therapeutics' Enhanze Technology Large Protein Molecule,Therapeutic Clinical Trial Results Presented at the 34th Annual,Meeting of the Controlled Release Society 3Halozyme Therapeutics' Enhanze Technology Large Protein Molecule,Therapeutic Clinical Trial Results Presented at the 34th Annual,Meeting of the Controlled Release Society 4Halozyme Therapeutics' Enhanze Technology Large Protein Molecule,Therapeutic Clinical Trial Results Presented at the 34th Annual,Meeting of the Controlled Release Society 5
The Scorpio Knee's single axis design places the center of rotation deeper to the posterior condyles, increasing the length of the patello-femoral moment arm. Quadriceps efficiency may then be increa
The Maxim knee system's curved-on-curved articulation maintains full inter-changeability. Modular tibial components offer excellent sizing options for better patient fit. The Maxim knee employs Titan
Primary and Posterior Stabilized Components.
...trak system includes a cruciate sparing version wh...with both resurfacing and inset patellas. Precisio...ematics and fit with tibial articular surface and ... locations provide easy intraoperative change of s...
Medicine Products: